Cabergoline
- 1 February 1995
- journal article
- research article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 49 (2), 255-279
- https://doi.org/10.2165/00003495-199549020-00009
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Pharmacodynamics and Relative Bioavailability of Cabergoline Tablets vs Solution in Healthy VolunteersJournal of Pharmaceutical Sciences, 1994
- Dose‐dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre studyClinical Endocrinology, 1992
- Excretion Balance and Urinary Metabolic Pattern of [3H] Cabergoline in ManDrug Metabolism and Drug Interactions, 1992
- Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.BMJ, 1991
- Natural History of HyperprolactinemiaAnnals of the New York Academy of Sciences, 1991
- Cabergoline versus Bromocriptine in Suppression of Lactation after Cesarean DeliveryGynecologic and Obstetric Investigation, 1991
- EFFECT OF SUBACUTE CABERGOLINE TREATMENT ON PROLACTIN, THYROID STIMULATING HORMONE AND GROWTH HORMONE RESPONSE TO SIMULTANEOUS ADMINISTRATION OF THYROTROPHIN‐RELEASING HORMONE AND GROWTH HORMONE‐RELEASING HORMONE IN HYPERPROLACTINAEMIC WOMENClinical Endocrinology, 1989
- Therapeutic Applications of Bromocriptine in Endocrine and Neurological DiseasesDrugs, 1988
- Bromocriptine in pregnancy: Safety aspectsKlinische Wochenschrift, 1987
- Correlation between inhibitory effect on prolactin secretion and antitumor activity of new ergoline compounds on DMBA-induced tumors in ratsEuropean Journal of Cancer and Clinical Oncology, 1983